Lataa...
Immune checkpoints in targeted-immunotherapy of pancreatic cancer: New hope for clinical development
Immunotherapy has been recently considered as a promising alternative for cancer treatment. Indeed, targeting of immune checkpoint (ICP) strategies have shown significant success in human malignancies. However, despite remarkable success of cancer immunotherapy in pancreatic cancer (PCa), many of th...
Tallennettuna:
| Julkaisussa: | Acta Pharm Sin B |
|---|---|
| Päätekijät: | , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8144893/ https://ncbi.nlm.nih.gov/pubmed/34094821 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2020.12.011 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|